BEIGENE, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.9 EUR | +3.48% |
|
+5.45% | -6.45% |
| 12/06 | Beijing Gene Announces Dose the First Five Patients in Its First-In-Human Phase 1 Trial to Evaluate BG-68501 | CI |
| 12/06 | Beigene Issues Shares Under Incentive Schemes | MT |
